Auftragnehmer
JANSSEN-CILAG, S.A.
ESP / Madrid / 28042
Insgesamt vergeben
€21M
Gewonnene Vergaben
21
Gewonnene Lose
87
Letzte Vergabe
07. Juli 2026
Vergebene Lose
| Los | CPV | Vertragsart | Vergabewert | Geschätzter Wert | Ort | Vergabekriterien |
|---|---|---|---|---|---|---|
LOT-0001 / Lote 1: Fármacos exclusivos de Janssen-Cilag de consumo actual en el Hospital. | Various medicinal products | supplies | €77.8M | €93.4M | ESP / Barcelona | price |
LOT-0001 / 1 - L1_USTEKINUMAB (DOE) | Pharmaceutical products | supplies | €19.3M | - | - | price |
LOT-0002 / Suministro sucesivo del medicamento Daratumumab para los centros hospitalarios de Servicio Gallego de Salud | Antineoplastic agents | supplies | €17.9M | €39.4M | ESP / Santiago de Compostela | price / 100 |
LOT-0031 / stelara 90 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €8.55M | - | - | price |
LOT-0031 / stelara 90 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €8.55M | - | - | price |
LOT-0002 / Lote 2: Fármacos exclusivos de Janssen-Cilag de consumo futuro en el Hospital. | Various medicinal products | supplies | €7.32M | €8.79M | ESP / Barcelona | price |
LOT-0012 / stelara 90 mg 1 jeringa precargada 1 ml | Antineoplastic and immunomodulating agents | supplies | €6.42M | 277.319 € | - | price |
LOT-0012 / stelara 90 mg 1 jeringa precargada 1 ml | Antineoplastic and immunomodulating agents | supplies | €6.42M | 277.319 € | - | price |
LOT-0007 / imbruvica 420 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | €5.03M | 556.013 € | - | price |
LOT-0007 / imbruvica 420 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | €5.03M | 556.013 € | - | price |
77 weitere Zeilen anzeigen
LOT-0013 / stelara 130mg 1 vial concentrado perfusion 26 ml | Antineoplastic and immunomodulating agents | supplies | €2.78M | €1.02M | - | price |
LOT-0013 / stelara 130mg 1 vial concentrado perfusion 26 ml | Antineoplastic and immunomodulating agents | supplies | €2.78M | €1.02M | - | price |
LOT-0022 / symtuza 800 mg/150 mg/200 mg/10 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €2.74M | €13.7M | - | price |
LOT-0022 / symtuza 800 mg/150 mg/200 mg/10 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €2.74M | €13.7M | - | price |
LOT-0025 / tremfya 100 mg 1 pluma solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | €2.63M | €1.98M | - | price |
LOT-0025 / tremfya 100 mg 1 pluma solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | €2.63M | €1.98M | - | price |
LOT-0005 / Suministro sucesivo del medicamento Talquetamab para los centros hospitalarios de Servicio Gallego de Salud | Antineoplastic agents | supplies | €1.93M | €4.25M | ESP / Santiago de Compostela | price / 100 |
LOT-0000 / Acuerdo Marco para el suministro de SYMTUZA® a los centros penitenciarios dependientes de la Secretaría General de Instituciones Penitenciarias. | Pharmaceutical products | supplies | €1.58M | - | - | quality / 5 |
LOT-0030 / stelara 45 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €1.5M | - | - | price |
LOT-0030 / stelara 45 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €1.5M | - | - | price |
LOT-0000 / Acuerdo Marco para el suministro de TREVICTA_BYANNLI® a los centros penitenciarios dependientes de la Secretaría General de Instituciones Penitenciarias. | Pharmaceutical products | supplies | €1.32M | - | - | quality / 5 |
LOT-0016 / Etravirina 200 mg comprimidos oral | Various medicinal products | supplies | €1.27M | €1.01M | ESP | price / 100 |
LOT-0004 / Trevicta 525 mg | Various medicinal products | supplies | €1.24M | €11.2M | ESP | price / 100 |
LOT-0020 / byannli 1.000 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | €1.24M | €1.91M | - | price |
LOT-0020 / byannli 1.000 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | €1.24M | €1.91M | - | price |
LOT-0006 / Suministro sucesivo del medicamento Teclistamab para los centros hospitalarios de Servicio Gallego de Salud | Antineoplastic agents | supplies | €1.16M | €2.56M | ESP / Santiago de Compostela | price / 100 |
LOT-0011 / stelara 45 mg 1 jeringa precargada 0.5 ml | Antineoplastic and immunomodulating agents | supplies | €1.07M | 171.148 € | - | price |
LOT-0011 / stelara 45 mg 1 jeringa precargada 0.5 ml | Antineoplastic and immunomodulating agents | supplies | €1.07M | 171.148 € | - | price |
LOT-0006 / imbruvica 560 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €1.05M | 272.475 € | - | price |
LOT-0006 / imbruvica 560 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €1.05M | 272.475 € | - | price |
LOT-0001 / LOTE 2:MEDICAMENTOS ONCOLÓGICOS (I) | General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Antineoplastic agents | supplies | 969.614 € | €22M | ESP / Sabadell | quality / 5 |
LOT-0019 / trevicta 525 mg 1 jeringa susp inyect lib prol 2,625 ml | Antineoplastic and immunomodulating agents | supplies | 732.132 € | €14.3M | - | price |
LOT-0019 / trevicta 525 mg 1 jeringa susp inyect lib prol 2,625 ml | Antineoplastic and immunomodulating agents | supplies | 732.132 € | €14.3M | - | price |
LOT-0021 / byannli 700 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | 650.784 € | €3.08M | - | price |
LOT-0021 / byannli 700 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | 650.784 € | €3.08M | - | price |
LOT-0024 / tremfya 100 mg 1 jeringa solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | 592.740 € | €1.83M | - | price |
LOT-0024 / tremfya 100 mg 1 jeringa solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | 592.740 € | €1.83M | - | price |
LOT-0003 / Trevicta 350 mg | Various medicinal products | supplies | 554.422 € | €5M | ESP | price / 100 |
LOT-0008 / imbruvica 280 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | 523.990 € | €5.56M | - | price |
LOT-0008 / imbruvica 280 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | 523.990 € | €5.56M | - | price |
LOT-0017 / Rilpivirina 25 mg comprimidos oral | Various medicinal products | supplies | 457.912 € | €1.58M | ESP | price / 100 |
LOT-0028 / spravato 28 mg solucion pulverizacion nasal | Antineoplastic and immunomodulating agents | supplies | 381.640 € | €44.5M | - | price |
LOT-0028 / spravato 28 mg solucion pulverizacion nasal | Antineoplastic and immunomodulating agents | supplies | 381.640 € | €44.5M | - | price |
LOT-0023 / rezolsta 800/150mg 30 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 366.656 € | 91.749 € | - | price |
LOT-0023 / rezolsta 800/150mg 30 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 366.656 € | 91.749 € | - | price |
LOT-0027 / ponvory 20 mg 28 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 352.880 € | €7.78M | - | price |
LOT-0027 / ponvory 20 mg 28 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 352.880 € | €7.78M | - | price |
LOT-0002 / Apalutamida 240mg oral | Various medicinal products | supplies | 325.926 € | 340.740 € | ESP | price / 100 |
LOT-0002 / Trevicta 263 mg | Various medicinal products | supplies | 282.681 € | €2.55M | ESP | price / 100 |
LOT-0018 / trevicta 350 mg 1 jeringa susp inyect lib prol 1,75 ml | Antineoplastic and immunomodulating agents | supplies | 271.160 € | €4.88M | - | price |
LOT-0018 / trevicta 350 mg 1 jeringa susp inyect lib prol 1,75 ml | Antineoplastic and immunomodulating agents | supplies | 271.160 € | €4.88M | - | price |
LOT-0000 / suministro del medicamento SIRTURO 100 mg comprimido oral principio activo BEDAQUILINA, SPRAVATO 28 mg solución PULVERIZ NASAL principio activo ESKETAMINA, Y PONVORY 20 mg comprimido oral, principio activo PONESIMOD, con destino Servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria | Various medicinal products | supplies | 267.102 € | - | - | price / 100 |
LOT-0001 / Trevicta 175 mg | Various medicinal products | supplies | 226.454 € | €2.04M | ESP | price / 100 |
LOT-0000 / Acuerdo Marco para el suministro de REZOLSTA® a los centros penitenciarios dependientes de la Secretaría General de Instituciones Penitenciarias. | Pharmaceutical products | supplies | 214.494 € | - | - | quality / 5 |
LOT-0001 / Suministro de Ponesimod (DOE) | Pharmaceutical products | supplies | 190.555 € | - | - | price |
LOT-0016 / trevicta 175 mg 1 jeringa susp inyect lib prol 0,875 ml | Antineoplastic and immunomodulating agents | supplies | 135.580 € | €5.5M | - | price |
LOT-0016 / trevicta 175 mg 1 jeringa susp inyect lib prol 0,875 ml | Antineoplastic and immunomodulating agents | supplies | 135.580 € | 272.475 € | - | price |
LOT-0002 / 2 - L2_RILPIVIRINA (DOE) | Pharmaceutical products | supplies | 131.305 € | - | - | price |
LOT-0017 / trevicta 263 mg 1 jeringa susp inyect lib prol 1,315 ml | Antineoplastic and immunomodulating agents | supplies | 122.253 € | €9.3M | - | price |
LOT-0017 / trevicta 263 mg 1 jeringa susp inyect lib prol 1,315 ml | Antineoplastic and immunomodulating agents | supplies | 122.253 € | €9.3M | - | price |
LOT-0010 / stelara 45mg 1 vial solucion inyectable | Antineoplastic and immunomodulating agents | supplies | 106.926 € | €14.5M | - | price |
LOT-0010 / stelara 45mg 1 vial solucion inyectable | Antineoplastic and immunomodulating agents | supplies | 106.926 € | €14.5M | - | price |
LOT-0029 / sirturo 100mg 24 comprimidos | Antineoplastic and immunomodulating agents | supplies | 95.740 € | - | - | price |
LOT-0029 / sirturo 100mg 24 comprimidos | Antineoplastic and immunomodulating agents | supplies | 95.740 € | 37.419 € | - | price |
LOT-0015 / dacogen 50mg 1 vial polvo concentrado solucion perfusion | Antineoplastic and immunomodulating agents | supplies | 53.331 € | €2.04M | - | price |
LOT-0015 / dacogen 50mg 1 vial polvo concentrado solucion perfusion | Antineoplastic and immunomodulating agents | supplies | 53.331 € | €2.04M | - | price |
LOT-0001 / 1 - PONVORY | Pharmaceutical products | supplies | 52.932 € | 52.941 € | ESP / Logroño | cost / 100 |
LOT-0009 / imbruvica 140 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | 52.399 € | €33.4M | - | price |
LOT-0009 / imbruvica 140 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | 52.399 € | €33.4M | - | price |
LOT-0004 / edurant 25mg 30 comprimidos recubiertos pelicula | Antineoplastic and immunomodulating agents | supplies | 41.684 € | €26.2M | - | price |
LOT-0004 / edurant 25mg 30 comprimidos recubiertos pelicula | Antineoplastic and immunomodulating agents | supplies | 41.684 € | €26.2M | - | price |
LOT-0020 / Apalutamida 60 mg comprimidos oral | Various medicinal products | supplies | 34.720 € | €8.42M | ESP | price / 100 |
LOT-0014 / intelence 200 mg 60 comprimidos | Antineoplastic and immunomodulating agents | supplies | 32.913 € | 917.608 € | - | price |
LOT-0014 / intelence 200 mg 60 comprimidos | Antineoplastic and immunomodulating agents | supplies | 32.913 € | 917.608 € | - | price |
LOT-0003 / Etravirina 200mg oral | Various medicinal products | supplies | 18.147 € | 19.748 € | ESP | price / 100 |
LOT-0026 / ponvory 2-3-4-5-6-7-8-9-10 mg 14 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 17.644 € | 497.874 € | - | price |
LOT-0026 / ponvory 2-3-4-5-6-7-8-9-10 mg 14 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 17.644 € | 497.874 € | - | price |
LOT-0001 / Apalutamida 60mg oral | Various medicinal products | supplies | 14.815 € | 15.488 € | ESP | price / 100 |
LOT-0001 / TREVICTA 263 MG SUSPENSION INYECTABLE LIBERACION PROLONGADA JERINGA | Pharmaceutical products | supplies | 8.823 € | - | ESP | cost |
LOT-0000 / TREVICTA 175 MG SUSPENSION INYECTABLE LIBERACION PROLONGADA JERINGA | Pharmaceutical products | supplies | 5.871 € | - | ESP | cost |
LOT-0001 / Suministro sucesivo del medicamento CILTACABTAGÉN AUTOLEUCEL | Antineoplastic agents | supplies | - | €86.8M | ESP / Vigo | cost |
LOT-0003 / Darunavir / Cobicistat comprimidos (800 / 150) mg, Etravirina comprimidos 200 mg, Rilpivirina comprimidos 25 mg | Antivirals for systemic use | supplies | - | €10.1M | ESP | price / 100 |
LOT-0001 / Suministro sucesivo del medicamento "CILTACABTAGEN AUTOLEUCEL". | Antineoplastic agents | supplies | - | €86.8M | ESP / A Coruña | cost |
LOT-0001 / UPTRAVI 1200 MCG 60 COMP. | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0002 / INTELENCE 200 MG 60 COMP. | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0004 / SPRAVATO 28 MG SOLUCION PARA PULVERIZACION NASAL | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0002 / Lote 8 AM SUM | Various medicinal products Pharmaceutical products | supplies | - | - | ESP | price |
Vergaben
11 weitere Zeilen anzeigen
Unternehmensdetails
Kennungen
A28925899
Länder
ESP
Städte
Madrid
Postleitzahlen
28042
E-Mails
Websites
CPV-Codes
Größe
large
Über diesen Auftragnehmer
JANSSEN-CILAG, S.A. ist ein Auftragnehmer, dem öffentliche Aufträge aus offiziellen europäischen Beschaffungssystemen vergeben wurden.
Dieses Profil fasst öffentlich verfügbare Beschaffungsinformationen zusammen, darunter vergebenen Vertragswert, vergebene Lose, Beschaffungshistorie, Länder der Tätigkeit, CPV-Klassifikationen und aktuelle Zuschläge.
FAQ
Welche Informationen enthält dieses Auftragnehmerprofil?
Dieses Profil fasst öffentlich verfügbare Beschaffungsinformationen über den Auftragnehmer zusammen, darunter vergebene Vertragswerte, vergebene Lose, Beschaffungshistorie, CPV-Klassifikationen, Standorte und Unternehmensdetails, sofern verfügbar.
Was bedeutet Insgesamt vergeben?
Insgesamt vergeben bezeichnet den bekannten Gesamtwert der diesem Auftragnehmer zugeordneten vergebenen Verträge auf Basis verfügbarer Beschaffungsdaten.
Warum kann der vergebene Wert vom gesamten Vertragswert abweichen?
Ein Auftragnehmer kann ein oder mehrere Lose innerhalb eines Vergabeverfahrens erhalten. Deshalb kann der an den Auftragnehmer vergebene Wert vom Gesamtwert der Vergabebekanntmachung abweichen.
Was sind vergebene Lose?
Vergebene Lose sind einzelne Teile eines Vergabeverfahrens, die diesem Auftragnehmer zugeschlagen wurden.
Wie oft wird dieses Profil aktualisiert?
Auftragnehmerprofile werden automatisch aktualisiert, wenn neue Vergabebekanntmachungen und Zuschlagsbekanntmachungen verfügbar werden.
Warum fehlen einige Unternehmensdetails?
Auftragnehmerprofile werden aus öffentlich verfügbaren Vergabebekanntmachungen erstellt. Einige Informationen, etwa Kontaktdaten oder Unternehmensregistrierungsdaten, sind nicht in jeder Bekanntmachung verfügbar.
Dieses Auftragnehmerprofil verstehen
Dieses Auftragnehmerprofil wird aus öffentlich verfügbaren Beschaffungsinformationen erstellt, die von öffentlichen Auftraggebern veröffentlicht werden.
Das Profil hilft Beschaffungsfachleuten, Lieferanten, Forschern und Journalisten, die Beteiligung eines Auftragnehmers an öffentlichen Vergaben zu verstehen.
Die Informationen können vergebene Vertragswerte, vergebene Lose, Beschaffungshistorie, Beschaffungskategorien (CPV), Standorte und öffentliche Auftraggeber umfassen.